DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
18.55
+0.06 (0.32%)
May 8, 2026, 3:00 PM CST

SHA:603233 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6,8976,5096,2174,4164,4932,792
Short-Term Investments
--6---
Trading Asset Securities
213.71438.9615.5141.9991.99109.37
Cash & Short-Term Investments
7,1116,9486,2384,4584,5852,902
Cash Growth
5.54%11.38%39.92%-2.76%58.01%-34.65%
Accounts Receivable
1,2941,2811,3031,2341,022743.82
Other Receivables
410.06406.51400.08436.53368.24308.18
Receivables
1,7041,6881,7031,6711,3901,052
Inventory
4,3434,1414,1284,1813,8723,630
Prepaid Expenses
--24.7511.9739.0343.79
Other Current Assets
720.26603.32491.86476.21783.06240.19
Total Current Assets
13,87813,38112,58610,79810,6707,868
Property, Plant & Equipment
6,6426,7607,3057,3016,0955,654
Long-Term Investments
158.26158.26155.59155.59132.16150.17
Goodwill
3,4683,4683,5223,0242,3642,060
Other Intangible Assets
1,9551,9661,9691,859637.19618.8
Long-Term Deferred Tax Assets
219.55217.8231.61214.48186.31157.57
Long-Term Deferred Charges
486.31515648.03670.03663.03669.76
Other Long-Term Assets
22.5421.7922.22101.1294.19157.99
Total Assets
26,83026,48726,44024,12320,84117,336
Accounts Payable
10,1679,9378,4336,8716,1274,738
Accrued Expenses
310.9482.99685.93757.54809.87488.83
Short-Term Debt
10.54268.31,982744.89697.31165.44
Current Portion of Long-Term Debt
2,5452,54242.2814.847.64-
Current Portion of Leases
--1,1771,041974.67905.59
Current Income Taxes Payable
405.47318.7137.64176.21138.4198.67
Current Unearned Revenue
467.31469.11408.81362.4435.73164.11
Other Current Liabilities
1,0621,049839.681,486516.59615.14
Total Current Liabilities
14,96815,06713,70711,4549,7087,176
Long-Term Debt
500.88463.031,8461,6381,4611,252
Long-Term Leases
2,1102,2272,6973,0702,7902,952
Long-Term Unearned Revenue
14.6814.9817.4219.317.6420.12
Other Long-Term Liabilities
53.7353.4234.849.670.33-
Total Liabilities
17,64717,82618,30216,19013,97711,400
Common Stock
1,1391,1391,1391,139949.12790.93
Additional Paid-In Capital
1,2521,2591,2881,3551,5371,643
Retained Earnings
5,3914,8804,3814,1703,5732,933
Treasury Stock
-100.74-100.74-100.74-29.72-36.68-77.59
Comprehensive Income & Other
189.92189.92189.92189.94189.94189.96
Total Common Equity
7,8717,3686,8976,8246,2125,479
Minority Interest
1,3111,2941,2411,109652.27457.3
Shareholders' Equity
9,1838,6618,1387,9336,8645,936
Total Liabilities & Equity
26,83026,48726,44024,12320,84117,336
Total Debt
5,1675,5007,7446,5085,9315,275
Net Cash (Debt)
1,9441,448-1,506-2,050-1,346-2,373
Net Cash Per Share
1.701.27-1.33-1.81-1.18-2.10
Filing Date Shares Outstanding
1,1361,1611,1391,1391,1391,139
Total Common Shares Outstanding
1,1361,1611,1391,1391,1391,139
Working Capital
-1,090-1,687-1,121-655.27962.03692.26
Book Value Per Share
6.936.346.065.995.454.81
Tangible Book Value
2,4481,9341,4061,9413,2112,800
Tangible Book Value Per Share
2.161.671.231.702.822.46
Buildings
--2,6572,0161,076800.43
Machinery
--1,5981,4601,2571,119
Construction In Progress
--487.75874.531,049765.67
Source: S&P Global Market Intelligence. Standard template. Financial Sources.